Insider Transactions in Q3 2021 at Avantor, Inc. (AVTR)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 20
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
141,300
-10.07%
|
$5,934,600
$42.37 P/Share
|
Sep 01
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Direct |
100,000
-7.82%
|
$3,900,000
$39.45 P/Share
|
Aug 26
2021
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
17,383
-55.13%
|
$695,320
$40.08 P/Share
|
Aug 20
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Direct |
100,000
-7.25%
|
$3,800,000
$38.81 P/Share
|
Jul 30
2021
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
81,125
-35.19%
|
$3,001,625
$37.24 P/Share
|
Jul 30
2021
|
Gerard Brophy EVP, Biopharma Production |
BUY
Exercise of conversion of derivative security
|
Direct |
81,125
+26.03%
|
$1,865,875
$23.2 P/Share
|
Jul 20
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
6,112
-7.11%
|
$226,144
$37.0 P/Share
|
Jul 15
2021
|
John Carethers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,565
+50.0%
|
-
|
Jul 12
2021
|
Jo Natauri Director |
BUY
Open market or private purchase
|
Indirect |
300
+0.05%
|
$10,800
$36.33 P/Share
|
Jul 09
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
18,331
-9.15%
|
$641,585
$35.6 P/Share
|